The current understanding is that the signal processing in individuals who will develop Alzheimer's disease and Parkinson's disease is altered years before the first clinical manifestation of these conditions. The new treatments we envision will restore the normal signaling in the newly-discovered brain network early on in the course of AD and PD to prevent and delay the neuronal loss and ensuing neurodegeneration.  

---